| Jaskern Dhami, | |
|
5375 Coit Rd Ste 100, Frisco, TX 75035-4911 | |
| (972) 712-7773 | |
| Not Available |
| Full Name | Jaskern Dhami |
|---|---|
| Gender | Male |
| Speciality | Podiatrist - Foot & Ankle Surgery |
| Location | 5375 Coit Rd Ste 100, Frisco, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225680259 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213ES0103X | Podiatrist - Foot & Ankle Surgery | 692078 (Texas) | Primary |
| Provider Name | Tavakoli Knapp Associates Pa |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1639120421 PECOS PAC ID: 4284670829 Enrollment ID: O20050705000715 |
News Archive
An international research collaboration has identified 13 new gene sites associated with the risk of coronary artery disease and validated 10 sites found in previous studies. Several of the novel sites discovered in the study, which is being published online in Nature Genetics, do not appear to relate to known risk factors, suggesting previously unsuspected mechanisms for cardiovascular disease.
A Toll-like receptor (TLR) agonist, called imiquimod, which activates dendritic cells, is in clinical use as a topical application for basal cell carcinoma. In addition, a number of TLR agonists have been evaluated in clinical trials as an adjuvant for cancer vaccines.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
New Orleans residents continue to face a three-fold increased risk of heart attack post-Katrina-a trend that has remained unchanged since the storm hit in 2005, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jaskern Dhami, 5375 Coit Rd Ste 100, Frisco, TX 75035-4911 Ph: (214) 284-5287 | Jaskern Dhami, 5375 Coit Rd Ste 100, Frisco, TX 75035-4911 Ph: (972) 712-7773 |
News Archive
An international research collaboration has identified 13 new gene sites associated with the risk of coronary artery disease and validated 10 sites found in previous studies. Several of the novel sites discovered in the study, which is being published online in Nature Genetics, do not appear to relate to known risk factors, suggesting previously unsuspected mechanisms for cardiovascular disease.
A Toll-like receptor (TLR) agonist, called imiquimod, which activates dendritic cells, is in clinical use as a topical application for basal cell carcinoma. In addition, a number of TLR agonists have been evaluated in clinical trials as an adjuvant for cancer vaccines.
MultiCell Technologies, Inc. has launched a new website with a fresh new look and updated information about discovery technology platforms and lead drug candidates. It also provides information to answer investors' most common questions.
Today, the U.S. Food and Drug Administration approved Tagrisso (osimertinib) as the first adjuvant treatment for patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation.
New Orleans residents continue to face a three-fold increased risk of heart attack post-Katrina-a trend that has remained unchanged since the storm hit in 2005, according to research being presented at the American College of Cardiology's 62nd Annual Scientific Session.
› Verified 4 days ago
Dr. Thomas Huu Tran, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 7533 Trailway Drive, Frisco, TX 75035 Phone: 972-335-9071 Fax: 972-335-8920 | |
Southwestern Foot & Ankle Associates, P.c. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3880 Parkwood Blvd, Suite 602, Frisco, TX 75034 Phone: 972-335-9071 Fax: 972-335-8920 | |
Texas Family Footcare Pa Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 5575 Warren Pkwy, Suite 101, Frisco, TX 75034 Phone: 972-712-4161 Fax: 972-412-4289 | |
Stonebriar Foot & Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 5575 Warren Pkwy Ste 101, Frisco, TX 75034 Phone: 972-712-4161 Fax: 972-712-4289 | |
Footcare, P.a. Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9300 John Hickman Pkwy Ste 1304, Frisco, TX 75035 Phone: 972-939-1757 Fax: 972-939-1682 | |
Premier Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 9359 Legacy Dr Ste 300b, Frisco, TX 75033 Phone: 217-473-5877 Fax: 972-270-7759 |